Tainkang: Wholly-owned subsidiary received the registration certificate of Nimodipine injection.

Taiencon announced that its wholly-owned subsidiary, Shandong Huabo Kaisheng Biotechnology Co., Ltd., recently received the "Drug Registration Certificate" for Nimodipine Injection issued by the National Medical Products Administration. Nimodipine injection was developed by German company Bayer Vital GmbH. In 1985, Nimodipine injection was first approved for sale in Germany under the trade name Nimotop, with a specification of 50ml:10mg. In 2004, the original research Nimodipine injection was imported into China.